Mukanov , K.K., K.N. Mukantayev, and P. Tarlykov. 2018. “GPR161 RECEPTOR AS A NOVEL TARGET FOR ANTIBODY-BASED IMMUNOTHERAPY OF TRIPLE-NEGATIVE BREAST CANCER”. Eurasian Journal of Applied Biotechnology, no. 1 (January). https://doi.org/10.11134/btp.1.2018.4.